文献速递神经肿瘤

MCM7表达是手术切除脑膜瘤患者复发的有前景预测指标

MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas.
PubMed 文献 · J Neurooncol · 2016-11-21

该回顾性研究分析160例手术切除脑膜瘤患者,在组织芯片中测定MIB-1与MCM7增殖指数。复发性脑膜瘤MCM7增殖指数显著高于非复发性脑膜瘤(p=0.020),而核分裂指数和MIB-1增殖指数未达统计学显著(p≥0.547)。MCM7增殖指数与无复发生存显著相关(COX多因素分析p=0.005),预测复发准确性最高。

要点

  • 复发性脑膜瘤MCM7增殖指数显著高于非复发性(p=0.020),核分裂指数与MIB-1无显著差异(p≥0.547)。
  • 复发预测最佳截断值:MIB-1增殖指数3%,MCM7增殖指数8%。
  • MCM7增殖指数与无复发生存显著相关(COX多因素p=0.005),MIB-1与核分裂指数无关联(p≥0.153)。

核心结论

  • MCM7增殖指数是比传统核分裂指数和MIB-1更好的识别脑膜瘤复发风险患者的方法,可能改善诊断、预后预测和治疗决策。

研究设计与样本

  • 回顾性分析160例手术切除脑膜瘤患者,在组织芯片中测定MIB-1和MCM7增殖指数(每1000个肿瘤细胞中阳性免疫反应细胞的百分比)。

主要发现

  • 复发性脑膜瘤MCM7增殖指数显著高于非复发性脑膜瘤(p=0.020),核分裂指数和MIB-1增殖指数未达统计学显著(p≥0.547)。
  • 复发预测最佳截断值:MIB-1增殖指数3%,MCM7增殖指数8%。
  • COX多因素生存分析显示MCM7增殖指数与无复发生存显著相关(p=0.005),核分裂指数和MIB-1无关联(p≥0.153)。
  • MCM7增殖指数预测复发最准确,获得最高灵敏度和最大ROC曲线下面积。

关键数值与推荐

  • 复发预测最佳截断值:MIB-1增殖指数3%,MCM7增殖指数8%。

临床怎么用

  • 作者认为MCM7增殖指数是比当前临床实践所用传统方法更好的识别脑膜瘤复发风险患者的方法,可能改善诊断、预后预测和治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with high risk of recurrence after meningioma resection might benefit from adjuvant radiation therapy and closer clinical follow-up. While the World Health Organization (WHO) classification and the MIB-1 biomarker are applied in the clinical practice to identify these patients, the reliability of these methods is questionable. To improve the prediction of tumor recurrence, this study evaluated and compared the prognostic usefulness of the biomarker MCM7 with the conventional mitotic index and the MIB-1 biomarker. One hundred sixty patients were retrospectively analyzed. The expression of MIB-1 and MCM7 was determined as proliferative indices (PI-percentage of positive immunoreactive cells among 1000 tumor cells) in tissue microarrays. MCM7 PI revealed significantly higher indices in recurrent meningiomas compared with non-recurrent meningiomas (p = 0.020), while mitotic index and MIB-1 PI did not reach statistical significance (p ≥ 0.547). The optimal cutoff values for recurrence prediction were 3% for MIB-1 PI and 8% for MCM7 PI. MCM7 PI was significantly associated with recurrence-free survival in COX multivariate survival analyses (p = 0.005), while no association was found with mitotic index or MIB-1 (p ≥ 0.153). MCM7 PI allowed for the most accurate prediction of recurrence, obtaining the highest sensitivity and the greatest area under the ROC curve. These results proved that MCM7 PI is a better method for identifying patients with risk of recurrence compared with the traditional methods used in the current clinical practice. MCM7 may thus improve diagnostics, prediction of prognosis and treatment decision making in patients suffering from meningiomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Winther TL, Torp SH. MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas. J Neurooncol. 2016. PMID: 27868157. doi:10.1007/s11060-016-2329-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。